학술논문
Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study
Document Type
Article
Author
Source
In: Scientific Reports . (Scientific Reports, December 2023, 13(1))
Subject
Language
English
ISSN
20452322